Analyst Ratings For Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO)
Today, Jefferies Financial Group reiterated its Buy rating on Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) with a price target of $420.00.
There are 3 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) is Buy with a consensus target price of $343.00 per share, a potential 14.91% upside.
Some recent analyst ratings include
- 9/24/2018-Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) had its Buy rating reiterated by Jefferies Financial Group with a $420.00 price target
- 9/20/2018-Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) has coverage initiated with a Equal ➝ Equal Weight rating and $335.00 price target
- 9/5/2018-Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) has coverage initiated with a Equal Weight rating and $345.00 price target
- 2/16/2018-Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) gets downgraded to Neutral by CL King
- 9/18/2017-Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) had its Buy rating reiterated by Deutsche Bank with a $255.00 price target
Recent Insider Trading Activity For Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO) has insider ownership of 27.99% and institutional ownership of 63.18%.
- On 12/14/2017 Christine A Tsingos, CFO, sold 4,980 with an average share price of $249.40 per share and the total transaction amounting to $1,242,012.00.
- On 12/4/2017 Michael Crowley, EVP, sold 1,000 with an average share price of $258.39 per share and the total transaction amounting to $258,390.00.
- On 11/30/2017 James R. Stark, VP, sold 746 with an average share price of $270.51 per share and the total transaction amounting to $201,800.46.
- On 11/14/2017 Giovanni Magni, EVP, sold 2,400 with an average share price of $253.01 per share and the total transaction amounting to $607,224.00.
- On 8/11/2017 Michael Crowley, EVP, sold 700 with an average share price of $215.91 per share and the total transaction amounting to $151,137.00.
- On 3/7/2017 Michael Crowley, EVP, sold 300 with an average share price of $196.13 per share and the total transaction amounting to $58,839.00.
- On 11/9/2016 James R. Stark, VP, sold 1,299 with an average share price of $171.42 per share and the total transaction amounting to $222,674.58.
Recent Trading Activity for Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE:BIO)
Shares of Bio-Rad Laboratories, Inc. Class A Common Stock closed the previous trading session at 298,49 −2,31 0,77 % with 301.46 shares trading hands.